Latest News

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
View full story

Post your comment.


  • Gene variants involved in stress responses affect 'post-concussive' symptoms

  • Tracing a path toward neuronal cell death

  • Income-based school assignment policy influences diversity, achievement

  • Low sugar diet makes foods taste sweeter but does not change preferred level of sweetness

  • Reduced blood flow seen in brain after clinical recovery of acute concussion

  • Newly evolved, uniquely human gene variants protect older adults from cognitive decline

  • Parental absence affects brain development in children

  • Aspirin targets key protein in neurodegenerative diseases

  • Could fish have consciousness? 'Emotional fever' experiment suggests they might

  • Threats against children during the separation process for women in abusive relationships